ACAT2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.670310E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.291050E-01
Normal-vs-Stage2
1.653850E-02
Normal-vs-Stage3
2.010800E-01
Normal-vs-Stage4
4.268200E-01
Stage1-vs-Stage2
5.007800E-01
Stage1-vs-Stage3
8.796000E-01
Stage1-vs-Stage4
6.317000E-01
Stage2-vs-Stage3
7.550000E-01
Stage2-vs-Stage4
8.386000E-01
Stage3-vs-Stage4
7.520200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.926380E-02
Normal-vs-AfricanAmerican
1.178970E-01
Normal-vs-Asian
9.635900E-02
Caucasian-vs-AfricanAmerican
7.725200E-01
Caucasian-vs-Asian
8.566200E-01
AfricanAmerican-vs-Asian
9.097200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.005700E-02
Normal-vs-Female
1.001940E-02
Male-vs-Female
7.036400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.188830E-01
Normal-vs-Age(41-60Yrs)
1.122190E-02
Normal-vs-Age(61-80Yrs)
2.595500E-02
Normal-vs-Age(81-100Yrs)
1.498440E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.323600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.344400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.064600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.456200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.682000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.376800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.716300E-02
Normal-vs-Daily Drinker
9.637600E-03
Normal-vs-Weekly Drinker
7.039900E-02
Normal-vs-Occasional Drinker
1.417690E-02
Normal-vs-Social Drinker
4.307700E-02
Non Drinker-vs-Daily Drinker
8.737500E-02
Non Drinker-vs-Weekly Drinker
7.951800E-01
Non Drinker-vs-Occasional Drinker
2.236600E-01
Non Drinker-vs-Social Drinker
7.884600E-01
Daily Drinker-vs-Weekly Drinker
2.617000E-01
Daily Drinker-vs-Occasional Drinker
6.668000E-01
Daily Drinker-vs-Social Drinker
2.185400E-01
Weekly Drinker-vs-Occasional Drinker
4.525200E-01
Weekly Drinker-vs-Social Drinker
9.922200E-01
Occasional Drinker-vs-Social Drinker
4.023400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.385200E-01
Normal-vs-Grade 2
2.751600E-01
Normal-vs-Grade 3
3.094000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.766200E-01
Grade 1-vs-Grade 3
5.467000E-01
Grade 1-vs-Grade 4
5.385200E-01
Grade 2-vs-Grade 3
3.560400E-01
Grade 2-vs-Grade 4
2.751600E-01
Grade 3-vs-Grade 4
3.094000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.080100E-02
Normal-vs-NonDiabetic
1.810340E-02
Diabetic-vs-NonDiabetic
4.293400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.066200E-01
Normal-vs-NoPancreatitis
8.862500E-03
Pancreatitis-vs-NoPancreatitis
5.767200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.301700E-02
Normal-vs-N1
1.614330E-02
N0-vs-N1
3.690000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.948300E-02
Normal-vs-TP53-NonMutant
3.138400E-02
TP53-Mutant-vs-TP53-NonMutant
2.276600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
